Zovighian Bernard J's Form 4 filing
Edwards Lifesciences CorpEW · filed Dec 10, 2025
- Accession no.
- 0001225208-25-009840
- Filed
- Dec 10, 2025
- Trade date
- Dec 8-10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.15M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zovighian Bernard JCIK 0001665141 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Common Stock | MOption exerciseAcquired | +25,350 | $59.26 | +$1,502,241 | 106,326 | Direct | |
| Dec 8, 2025 | Common Stock | SSaleDisposed | −21,487 | $85.21F2 | −$1,830,907.27 | 84,839 | Direct | |
| Dec 9, 2025 | Common Stock | GGiftDisposed | −3,863 | $0.00 | $0 | 80,976 | Direct | |
| Dec 9, 2025 | Common Stock | GGiftAcquired | +3,863 | $0.00 | $0 | 12,459.55 | Indirect | |
| Dec 10, 2025 | Common Stock | SSaleDisposed | −3,863 | $83.45 | −$322,367.35 | 8,596.55 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Common Stock | MOption exerciseDisposed | −25,350 | $0.00 | $0 | 25,350 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $84.63 to $85.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.